Guggenberger J, Kenndoff S, Taugner J, Kasmann L, et al. Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab. BMC Cancer 2022;22:317.
PMID: 35331196